Call: The FDA is again considering approval of an experimental weight loss drug it rejected a year ago over concerns about potential heart problems and birth defects in babies born to women who take the drug. California-based pharmaceutical company Vivus Inc, is now asking for limited approval for its oral combination drug Qnexa, which would […]
07
Dec
FDA reconsiders weight loss drug Qnexa
Posted In: Medical Weight Loss News By Dr. Lazarus
Tagged : appetite suppressant, phentermine, qnexa, topiramate, topomax, weight loss drug
Comments : 8 responses
